Back
Genpact Vs. Aligos Therapeutics Industry Stock Comparison
Buy
68
G
Genpact
Last Price:
$46.37
Seasonality Move:
1.47%
Sell
42
ALGS
Aligos Therapeutics
Last Price:
$31.95
Seasonality Move:
-27%
Sell
42
Aligos Therapeutics (ALGS)
is a Sell
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $33.79. The Score for ALGS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
ALGS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
G Stock Price Chart
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.79The current trend is moderately bearish and ALGS is experiencing slight buying pressure.
G Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 69.27 | Buy |
Chaikin Money Flow: | -554899 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.57 - 44.55) | Buy |
Bollinger Bands (100): | (38.63 - 44.63) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.72 | Buy |
Relative Strength Index (14 RSI): | 49.27 | Sell |
Chaikin Money Flow: | 70558 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.91 - 41.25) | Sell |
Bollinger Bands (100): | (7.73 - 31.51) | Buy |
G Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.47 | Buy |
20-day SMA: | 43.53 | Buy |
50-day SMA: | 44.41 | Buy |
200-day SMA: | 37.36 | Buy |
8-day EMA: | 44.69 | Buy |
20-day EMA: | 44.09 | Buy |
50-day EMA: | 43.36 | Buy |
200-day EMA: | 39.4 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.48 | Buy |
20-day SMA: | 37.94 | Sell |
50-day SMA: | 29.23 | Buy |
200-day SMA: | 17.52 | Buy |
8-day EMA: | 34.28 | Sell |
20-day EMA: | 35.08 | Sell |
50-day EMA: | 29.95 | Buy |
200-day EMA: | 20.76 | Buy |
Genpact Earnings Growth & G Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.31 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Genpact Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |